JNJ – johnson & johnson (US:NASDAQ)
Stock Stats
News
Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor
Johnson & Johnson (NYSE:JNJ) Stock Goes Ex-Dividend In Just Three Days [Yahoo! Finance]
Lung Cancer Surgery Market 2024 to 2034 Projected to Reach USD 2.5 Billion by 2034 with 5.7% CAGR | Future Market Insights, Inc. [Yahoo! Finance]
Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy [Yahoo! Finance]
Dr Oz nominated to lead CMS despite big pharma ties [Yahoo! Finance]
Form 13F-HR JOHNSON & JOHNSON For: Sep 30
Form 25-NSE JOHNSON & JOHNSON Filed by: NEW YORK STOCK EXCHANGE LLC
Form 4/A JOHNSON & JOHNSON For: May 01 Filed by: REED JOHN C
Form 10-Q JOHNSON & JOHNSON For: Sep 29
Form 4 JOHNSON & JOHNSON For: May 22 Filed by: Wolk Joseph J
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.